Safety of Common Inhaled Glucocorticosteroids for Childhood Asthma: A Systematic Analyse
WANG Feng-hua,ZHANG Ting,LIU Fang,ZHAI Suo-di,HU Yong-fang
2009-01-01
Abstract:OBJECTIVE:To assess the safety of inhaled glucocorticosteoids in the treatment of childhood asthma.METHODS:MEDLINE(1995～2007),PUBMED(1995～2007),Cochrane Central Register of Controlled Trials(Issue 1,2008),CNKI(1995～2007) and Wanfang Data were searched by computer for randomized controlled trials or quasi-randomized controlled trials about the safety of inhaled glucocorticosteoids in the treatment of childhood asthma.A meta-analysis was performed on the included studies.RESULTS:A total of twenty three literatures were included(n = 2 112),of which,16 were written in Chinese and 7 in English.According to Jadad scale,6 literatures were high in quality.In the inhaled glucocorticosteoids groups as compared with the control,(1) the urinary-free cortisol(UFC)(within 3 month) was higher than that for the control group [WMD:-11.67,95% CI(-19.68,-3.66),P=0.004],however,the UFC had no statistical difference over 1 year [WMD:-3.45,95%CI(-9.08,2.18),P=0.23];(2) Within 1 year and over 1 year,the growth velocity(GV) had no statistical difference (P0.05) [WMD:0.02,95% CI(-0.07,0.11),P=0.49 versus WMD:-0.22,95%CI(-0.53,0.09),P=1.40];(3) Similar results were also found in 6 month and 1 year for the bone mineral density(BMD) [WMD:0,95% CI(-0.01,0.01),P=0.95 versus WMD:0.01,95%CI(-0.01,0.02), P=0.24];(4) The C-terminal telopeptide region of type I(ICTP) collagen increased significantly within 6 months [WMD:-3.33,95% CI(-5.23,-1.42),P=0.000 6].Heterogeneity was only noted among literatures of ICTP(Heterogeneity test P0.000 01,I~2=96.4%),but sensitivity analysis showed that the analysis results of ICTP were stable and reliable.The literatures of other indexes were of homogenicity.The finding showed that the UFC of publication bias was existed.CONCLUSION:Although inhaled corticosteroids may have effect on adrenocortical function and growth development in short time(within 6 montsh),the clinical evidences available so far indicate that the treatment of childhood asthma with inhaled glucocorticosteroids had no effects on the growth velocity(over 1 year),adrenocortical function and bone mineral density,suggesting they are safe for children in long-term use.